EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Complement Dysregulation in Obese Versus Nonobese Polycystic Ovary Syndrome Patients

Alexandra E Butler, Abu Saleh Md Moin, Thozhukat Sathyapalan iD, Stephen L Atkin iD

Cells · 2023

DOI: 10.3390/cells12152002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2023. Verfasst von Alexandra E Butler und 3 weiteren Autor:innen. Beteiligte Einrichtung: Royal College of Surgeons in Ireland Bahrain, Busaiteen P.O. Box 15503, Adliya, Bahrain. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Obesity, Complement System Proteins. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Upregulation of complement system factors are reported to be increased in polycystic ovary syndrome (PCOS) and may be due to obesity and insulin resistance rather than inherently due to PCOS. We directly compared complement factors from an obese, insulin-resistant PCOS population to a nonobese, non-insulin-resistant PCOS population in a proteomic analysis to investigate this.

Methods

Plasma was collected from 234 women (137 with PCOS and 97 controls) from a biobank cohort and compared to a nonobese, non-insulin-resistant population (24 with PCOS and 24 controls). Slow off-rate modified aptamer (SOMA) scan plasma protein measurement was undertaken for the following complement system proteins: C1q, C1r, C2, C3, C3a, iC3b, C3b, C3d, C3adesArg, C4, C4a, C4b, C5, C5a, C5b-6 complex, C8, properdin, factor B, factor D, factor H, factor I, Mannose-binding protein C (MBL), complement decay-accelerating factor (DAF) and complement factor H-related protein 5 (CFHR5).

Results

The alternative pathway of the complement system was overexpressed in both obese and nonobese PCOS, with increased C3 (p < 0.05) and properdin (p < 0.01); additionally, factor B increased in obese PCOS (p < 0.01). For inhibitors of this pathway, factor I was increased (p < 0.01) in both slim and obese PCOS, with an increase in CFHR5 and factor H in obese PCOS (p < 0.01). Complement factors iC3b, C3d and C5a, associated with an enhanced B cell response and inflammatory cytokine release, were increased in both slim and obese PCOS (p < 0.05). C3a and its product, C3adesArg, were both significantly elevated in nonobese PCOS (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polycystic Ovary SyndromeObesityComplement System ProteinsHumansFemaleAdultInsulin ResistanceCase-Control StudiesYoung Adult

Stichwörter der Autor:innen

C3complement factorsfactor Bfactor Hpolycystic ovary syndromeproperdin

Substanzen

Complement System Proteins

Autor:innen und Institutionen

  • Royal College of Surgeons in Ireland Bahrain, Busaiteen P.O. Box 15503, Adliya, Bahrain.
  • Academic Endocrinology, Diabetes and Metabolism, Hull York Medical School, Hull HU6 7RU, UK.

ORCID-Profile: Thozhukat Sathyapalan, Stephen L Atkin

Zitieren

APA

Butler, A. E., Moin, A. S. M., Sathyapalan, T., & Atkin, S. L. (2023). Complement Dysregulation in Obese Versus Nonobese Polycystic Ovary Syndrome Patients. Cells. https://doi.org/10.3390/cells12152002

Vancouver

Butler AE, Moin ASM, Sathyapalan T, Atkin SL. Complement Dysregulation in Obese Versus Nonobese Polycystic Ovary Syndrome Patients. Cells. 2023. doi:10.3390/cells12152002

BibTeX
@article{Butler2023,
  author = {Butler, Alexandra E and Moin, Abu Saleh Md and Sathyapalan, Thozhukat and Atkin, Stephen L},
  title = {Complement Dysregulation in Obese Versus Nonobese Polycystic Ovary Syndrome Patients},
  journal = {Cells},
  year = {2023},
  doi = {10.3390/cells12152002}
}
Kostenlos starten →